Brief: Dr. Lal Pathlabs Ltd March-Quarter Consol Net Profit Down
May 17 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* DR. LAL PATHLABS LTD MARCH-QUARTER CONSOL NET PROFIT 613
MILLION
RUPEES VERSUS 834 MILLION RUPEES YEAR AGO
* DR. LAL PATHLABS LTD MARCH-QUARTER CONSOL REVENUE FROM
OPERATIONS 4.86 BILLION RUPEES VERSUS 4.31 BILLION RUPEES YEAR
AGO
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise